Straumann USA LLC recalls Straumann n!ce Zr
Includes an incorrect screw seat interface.
- Endosseous Dental Implant Abutment
- Under Investigation by firm
The FDA has posted 16 enforcement recalls of endosseous dental implant abutment devices since 2025, none of them Class I (most serious). Most recent report: May 6, 2026.
Includes an incorrect screw seat interface.
Includes an incorrect screw seat interface.
A material mix-up had occurred during the manufacturing of Straumann¿ Custom Abutments. More specifically, a raw material bar of TAN-material (SAP #701924 / Lot 7130439) was incorrectly identified as a Titanium Bar Ti Gr…
A material mix-up had occurred during the manufacturing of Straumann¿ Custom Abutments. More specifically, a raw material bar of TAN-material (SAP #701924 / Lot 7130439) was incorrectly identified as a Titanium Bar Ti Gr…
Incorrect titanium screw, packaged with dental implant.
Engaging titanium base was manufactured 180 degrees around the post from where it should be located in relation to the connection geometry;…
Due to manufacturing error, digital analog rotational feature is 180 degrees off.
Due to manufacturing issues, abutment products were manufactured with screw seat located too high, which may cause the mating screw to have a shorter engagement length into the associated implant.
Incorrect blister labelling.
Patient chart stickers provided inside the packaging may incorrectly identify ET Rigid Abutments as Regular version whereas the actual product is a Mini version;…
Patient chart stickers provided inside the packaging may incorrectly identify ET Rigid Abutments as Regular version whereas the actual product is a Mini version;…
Patient chart stickers provided inside the packaging may incorrectly identify ET Rigid Abutments as Regular version whereas the actual product is a Mini version;…
Source: U.S. FDA openFDA device enforcement reports, updated continuously. Device type per the FDA's RES classification (“Abutment, Implant, Dental, Endosseous”). Informational only — verify against the FDA before acting.